Gian Piero Reverberi

Senior Vice President & Chief Commercial Officer at Vanda Pharmaceuticals Inc.

Gian Piero Reverberi

Gian Piero Reverberi

Senior Vice President & Chief Commercial Officer at Vanda Pharmaceuticals Inc.

Overview
RelSci Relationships

922

Number of Boards

2

Birthday

1966

Age

53

Relationships
RelSci Relationships are individuals Gian Piero Reverberi likely has professional access to. A relationship does not necessarily indicate a personal connection.

President & Chief Executive Officer at Vanda Pharmaceuticals Inc.

Relationship likelihood: Strong

President & Chief Executive Officer at Aevi Genomic Medicine, Inc.

Relationship likelihood: Strong

Partner at Care Capital LLC

Relationship likelihood: Strong

Chief Financial Officer, Treasurer & Executive Vice President at Vanda Pharmaceuticals Inc.

Relationship likelihood: Strong

Senior Vice President General Counsel & Secretary at Vanda Pharmaceuticals Inc.

Relationship likelihood: Strong

Co-Founder & Head, Business Development at Vanda Pharmaceuticals Inc.

Relationship likelihood: Strong

Former Secretary, Senior Vice President & General Counsel at Vanda Pharmaceuticals Inc.

Relationship likelihood: Average

Senior Director Program Director at Vanda Pharmaceuticals Inc.

Relationship likelihood: Average

Former Partner at Ernst & Young LLP

Relationship likelihood: Average

Director at Atterx BioTherapeutics

Relationship likelihood: Average

Paths to Gian Piero Reverberi
Potential Connections via
Relationship Science
You
Gian Piero Reverberi
Senior Vice President & Chief Commercial Officer at Vanda Pharmaceuticals Inc.
Education
Class of 1994

SDA Bocconi School of Management was founded in 1971 as the Business School of Bocconi University. SDA Bocconi offers executive, custom and MBA programs, as well as specialised masters, and regularly takes on research projects on commission. In 1998, SDA Bocconi was the first school in Italy to be accredited by EQUIS and it’s now one of only 56 Business Schools worldwide to hold the so-called “triple crown”,having been accredited by three international accreditation associations: AACSB, EQUIS and AMBA (Association of MBAs).The School has also been accredited by CSQNet and holds the ISO 9001:2000 quality rating from the Funded Projects Services Center.

Class of 1988

The Sapienza University of Rome, officially Sapienza – Università di Roma, also called simply Sapienza formerly known as Università degli studi di Roma "La Sapienza", is a coeducational, autonomous state university in Rome, Italy. It is the oldest of Rome's four state-funded universities. In Italian, sapienza means "wisdom" or "knowledge".

Career History
Senior Vice President & Chief Commercial Officer
2015 - Current

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. It intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Senior Vice President
2006 - 2014

Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA

General Manager
2004 - 2006
Boards & Committees
Non-Executive Director
2018 - Current

Syncona Ltd. is a closed-end investment fund. It engages in delivering returns from investments in long and alternative investment funds across multiple asset classes and targets. The company operates through the following segments: Life science portfolio and Capital pool investments. The Life science portfolio segment activities focuses on developing products to deliver transformational treatments to patients. The Capital pool investments segment invests in a diversified portfolio of hedge, equity and long-term alternative investment funds across multiple asset classes. Syncona was founded on August 14, 2012 and is headquartered in St. Peter Port, the United Kingdom.

Chairman & Managing Director
Prior

Shire France SA manufactures pharmaceutical products. The firm offers prescriptions and proprietary drugs. It specializes in therapeutic areas such as hematology, nephrology, central nervous system, gastrointestinal, and genetic diseases. The company was founded in 1997 and is headquartered in Paris, France.

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Gian Piero Reverberi. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Gian Piero Reverberi's profile does not indicate a business or promotional relationship of any kind between RelSci and Gian Piero Reverberi.